ArticleOncotarget2017

Neutrophil-to-lymphocyte ratio predicts survival in European patients with hepatocellular carcinoma administered sorafenib.

Alberto Lué et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.